RxDoctor Payments Data

Scott Stuart, PA

Physician Assistant · Burley, IDNPI 1528533296

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (40.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Sanofi at 56.4% of the total. Reporting peaked in 2024 at $4,271 and has fallen 82.5% since, to $747 in 2025. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,715in general payments, 2019–2025

Across 169 payments — averaging $39.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$4K
  • Johnson & Johnson$512
  • AbbVie$396
  • UCB, Inc.$280
  • Amgen$256
  • E.r. Squibb & Sons, L.L.C.$254
  • plus $1K from 19 others

What the payments were for

  • Consulting fees$2,44236%
  • Travel & lodging$1,10616%
  • Food & beverage$2,71440%
  • Education$4537%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,715 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$276,113
Medicare patients
866
Services billed
17,670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab20$279,608
Dupixent PenDupilumab12$43,705
Fluorouracil26$3,294
Clobetasol Propionate92$2,912
Doxycycline Hyclate100$2,429
Imiquimod34$1,558
Clindamycin Phosphate20$1,451
Triamcinolone Acetonide75$878
Desonide16$759
Ketoconazole56$574
Minocycline Hcl20$477
MethotrexateMethotrexate Sodium28$394
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$139
Mupirocin19$91
Terbinafine Hcl12$58

Paid to pharmacies, not to this prescriber.

Other physician assistant in Burley

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →